跳至主要内容
临床试验/NCT01564316
NCT01564316终止不适用

Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2005年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
22
试验地点
1

研究概览

简要总结

Using to method of Proteomics, for aims to conquer intractable disease, try to access variety experiment. Biomarker is necessary to develop new diagnosis method and target of treatment.

详细描述

Following Seoul National University Hospital Institutional Review Board approval, obtain serum and platelet with neurodegeneration patients and control group visited the part of neurology, there'll be analysis to differentiate each other diseases use to method Proteomics. Biomarker will be screening via 1D/2D analysis, Mass analysis, database searching- the MASCOT search tool, SWISS-PROT and etc.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • neurodegeneration patients and control group include dementia patients visited the part of neurology.
  • over the age of 18
  • when participants can understand subject of this study
  • Total point of Mini Mental state exam(MMSE)should be Under 26 include MCI (mild cognitive impairment) and over GDS score 3points.
  • exclusion criteria:
  • under eighteen years of age
  • when participants cannot understand subject of this study
  • cannot accept this study

排除标准

  • 未提供

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验